1,390
Views
52
CrossRef citations to date
0
Altmetric
Research Article

Selection of oral bioavailability enhancing formulations during drug discovery

, , , , &
Pages 235-247 | Received 31 Jul 2010, Accepted 15 Sep 2010, Published online: 19 Aug 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Nithya Ramesh & Abul Kalam Azad Mandal. (2019) Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model. Drug Development and Industrial Pharmacy 45:9, pages 1506-1514.
Read now
Ossi Korhonen, Katja Pajula & Riikka Laitinen. (2017) Rational excipient selection for co-amorphous formulations. Expert Opinion on Drug Delivery 14:4, pages 551-569.
Read now
Narendar Dudhipala & Kishan Veerabrahma. (2015) Pharmacokinetic and pharmacodynamic studies of nisoldipine-loaded solid lipid nanoparticles developed by central composite design. Drug Development and Industrial Pharmacy 41:12, pages 1968-1977.
Read now
Anuj G. Agrawal, Ashok Kumar & Paraag S. Gide. (2015) Formulation of solid self-nanoemulsifying drug delivery systems using N-methyl pyrrolidone as cosolvent. Drug Development and Industrial Pharmacy 41:4, pages 594-604.
Read now
Hyun-Jong Cho, Ji-Eon Kim, Dae-Duk Kim & In-Soo Yoon. (2014) In vitro–in vivo extrapolation (IVIVE) for predicting human intestinal absorption and first-pass elimination of drugs: principles and applications. Drug Development and Industrial Pharmacy 40:8, pages 989-998.
Read now
Shiuan-Pey Lin, Yu-Chi Hou, Tzu-Yun Liao & Shang-Yuan Tsai. (2014) Enhancing the bioavailability of magnolol in rabbits using melting solid dispersion with polyvinylpyrrolidone. Drug Development and Industrial Pharmacy 40:3, pages 330-337.
Read now
Sorin Emilian Leucuta. (2014) Selecting oral bioavailability enhancing formulations during drug discovery and development. Expert Opinion on Drug Discovery 9:2, pages 139-150.
Read now

Articles from other publishers (45)

Jochem Alsenz & Elisabeth Haenel. (2023) Precellys® Evolution Homogenizer - a versatile instrument for milling, mixing, and amorphization of drugs in preformulation. European Journal of Pharmaceutics and Biopharmaceutics 189, pages 1-14.
Crossref
Abhijeet A. Aher, Karimunnisa S. Shaikh & Praveen D. Chaudhari. (2023) Stability of co-Amorphous Solid Dispersions: Physical and Chemical Aspects. Journal of Structural Chemistry 64:4, pages 686-738.
Crossref
Peter Kroll, Lara Exner, Christoph Brandenbusch & Gabriele Sadowski. (2022) Influence of Hydrophobic and Hydrophilic Chain Length of C i E j Surfactants on the Solubilization of Active Pharmaceutical Ingredients . Molecular Pharmaceutics 20:2, pages 1296-1306.
Crossref
Zhiqing Hu, Pengchong Xu, Eman A. Ashour & Michael A. Repka. (2022) Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs). AAPS PharmSciTech 23:6.
Crossref
Deepa Nakmode, Valamla Bhavana, Pradip Thakor, Jitender Madan, Pankaj Kumar Singh, Shashi Bala Singh, Jessica M. Rosenholm, Kuldeep K. Bansal & Neelesh Kumar Mehra. (2022) Fundamental Aspects of Lipid-Based Excipients in Lipid-Based Product Development. Pharmaceutics 14:4, pages 831.
Crossref
Yan-Yu Zhang, Yun-Da Yao, Jin-Fang Luo, Zhong-Qiu Liu, Yu-Ming Huang, Fei-Chi Wu, Qin-Hua Sun, Jian-Xin Liu & Hua Zhou. (2022) Microsomal prostaglandin E2 synthase-1 and its inhibitors: Molecular mechanisms and therapeutic significance. Pharmacological Research 175, pages 105977.
Crossref
Lijun Zhang, Hansen Luan, Weiyue Lu & Hao Wang. (2020) Preformulation Studies and Enabling Formulation Selection for an Insoluble Compound at Preclinical Stage—From In Vitro, In Silico to In Vivo. Journal of Pharmaceutical Sciences 109:2, pages 950-958.
Crossref
Daniel J. Price, Anita Nair, Johanna Becker-Baldus, Clemens Glaubitz, Martin Kuentz, Jennifer Dressman & Christoph Saal. (2020) Incorporation of HPMCAS during loading of glibenclamide onto mesoporous silica improves dissolution and inhibits precipitation. European Journal of Pharmaceutical Sciences 141, pages 105113.
Crossref
Luis Almeida e Sousa, Kata J. Dömötör, Mafalda Paiva & Constança Cacela. (2019) Drug-Polymer Solubility Determination: A New Thermodynamic Model Free from Lattice Theory Assumptions. Pharmaceutical Research 36:12.
Crossref
Aiguo Zeng, Xin Yao, Yue Gui, Yuhui Li, Karen J. Jones & Lian Yu. (2019) Inhibiting Surface Crystallization and Improving Dissolution of Amorphous Loratadine by Dextran Sulfate Nanocoating. Journal of Pharmaceutical Sciences 108:7, pages 2391-2396.
Crossref
Daniel J. Price, Anita Nair, Martin Kuentz, Jennifer Dressman & Christoph Saal. (2019) Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulations. European Journal of Pharmaceutical Sciences 132, pages 142-156.
Crossref
Daniel J Price, Felix Ditzinger, Niklas J Koehl, Sandra Jankovic, Georgia Tsakiridou, Anita Nair, René Holm, Martin Kuentz, Jennifer B Dressman & Christoph Saal. (2019) Approaches to increase mechanistic understanding and aid in the selection of precipitation inhibitors for supersaturating formulations – a PEARRL review. Journal of Pharmacy and Pharmacology 71:4, pages 483-509.
Crossref
Karthik Siram, S.M. Habibur Rahman, K. Balakumar, N. Duganath, R. Chandrasekar & R. Hariprasad. 2019. Biomedical Applications of Nanoparticles. Biomedical Applications of Nanoparticles 91 115 .
Scott V. Jermain, Chris Brough & Robert O. WilliamsIIIIII. (2018) Amorphous solid dispersions and nanocrystal technologies for poorly water-soluble drug delivery – An update. International Journal of Pharmaceutics 535:1-2, pages 379-392.
Crossref
Jin Wang, Ruimiao Chang, Yanan Zhao, Jiye Zhang, Ting Zhang, Qiang Fu, Chun Chang & Aiguo Zeng. (2017) Coamorphous Loratadine-Citric Acid System with Enhanced Physical Stability and Bioavailability. AAPS PharmSciTech 18:7, pages 2541-2550.
Crossref
Meng Li, Nicolas Ioannidis, Costas Gogos & Ecevit Bilgili. (2017) A comparative assessment of nanocomposites vs. amorphous solid dispersions prepared via nanoextrusion for drug dissolution enhancement. European Journal of Pharmaceutics and Biopharmaceutics 119, pages 68-80.
Crossref
Andreas Beyer, Holger Grohganz, Korbinian Löbmann, Thomas Rades & Claudia S. Leopold. (2017) Improvement of the physicochemical properties of Co-amorphous naproxen-indomethacin by naproxen-sodium. International Journal of Pharmaceutics 526:1-2, pages 88-94.
Crossref
Shayne Cox Gad. 2017. Oral Formulation Roadmap from Early Drug Discovery to Development. Oral Formulation Roadmap from Early Drug Discovery to Development 39 88 .
Dev Prasad, Akash Jain & Sudhakar Garad. 2017. Poorly Soluble Drugs. Poorly Soluble Drugs 125 186 .
Andreas Beyer, Holger Grohganz, Korbinian Löbmann, Thomas Rades & Claudia S. Leopold. (2016) Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin. European Journal of Pharmaceutics and Biopharmaceutics 109, pages 140-148.
Crossref
Amitava Mitra, Wei Zhu & Filippos Kesisoglou. (2016) Physiologically Based Absorption Modeling for Amorphous Solid Dispersion Formulations. Molecular Pharmaceutics 13:9, pages 3206-3215.
Crossref
Sara B.E. Andersson, Caroline Alvebratt, Jan Bevernage, Damien Bonneau, Claudia da Costa Mathews, Rikesh Dattani, Khadijah Edueng, Yan He, René Holm, Cecilie Madsen, Thomas Müller, Uwe Muenster, Anette Müllertz, Krista Ojala, Thomas Rades, Peter Sieger & Christel A.S. Bergström. (2016) Interlaboratory Validation of Small-Scale Solubility and Dissolution Measurements of Poorly Water-Soluble Drugs. Journal of Pharmaceutical Sciences 105:9, pages 2864-2872.
Crossref
Andreas Beyer, Lydia Radi, Holger Grohganz, Korbinian Löbmann, Thomas Rades & Claudia S. Leopold. (2016) Preparation and recrystallization behavior of spray-dried co-amorphous naproxen–indomethacin. European Journal of Pharmaceutics and Biopharmaceutics 104, pages 72-81.
Crossref
Christel A.S. Bergström, William N. Charman & Christopher J.H. Porter. (2016) Computational prediction of formulation strategies for beyond-rule-of-5 compounds. Advanced Drug Delivery Reviews 101, pages 6-21.
Crossref
Martin Kuentz, René Holm & David P. Elder. (2016) Methodology of oral formulation selection in the pharmaceutical industry. European Journal of Pharmaceutical Sciences 87, pages 136-163.
Crossref
Linda C. Alskär, Christopher J. H. Porter & Christel A. S. Bergström. (2015) Tools for Early Prediction of Drug Loading in Lipid-Based Formulations. Molecular Pharmaceutics 13:1, pages 251-261.
Crossref
Goedele Craye, Korbinian Löbmann, Holger Grohganz, Thomas Rades & Riikka Laitinen. (2015) Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying. Molecules 20:12, pages 21532-21548.
Crossref
Andreas Beyer, Holger Grohganz, Korbinian Löbmann, Thomas Rades & Claudia Leopold. (2015) Multivariate Quantification of the Solid State Phase Composition of Co-Amorphous Naproxen-Indomethacin. Molecules 20:10, pages 19571-19587.
Crossref
Yan He & Chris Ho. (2015) Amorphous Solid Dispersions: Utilization and Challenges in Drug Discovery and Development. Journal of Pharmaceutical Sciences 104:10, pages 3237-3258.
Crossref
Valeria Ferretti, Alessandro Dalpiaz, Valerio Bertolasi, Luca Ferraro, Sarah Beggiato, Federico Spizzo, Enzo Spisni & Barbara Pavan. (2015) Indomethacin Co-Crystals and Their Parent Mixtures: Does the Intestinal Barrier Recognize Them Differently?. Molecular Pharmaceutics 12:5, pages 1501-1511.
Crossref
Ann Newman. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia 1 32 .
Sudhakar Garad & Akash Jain. 2015. Discovering and Developing Molecules with Optimal Drug-Like Properties. Discovering and Developing Molecules with Optimal Drug-Like Properties 3 47 .
Riikka Laitinen, Korbinian Löbmann, Holger Grohganz, Clare Strachan & Thomas Rades. (2014) Amino Acids as Co-amorphous Excipients for Simvastatin and Glibenclamide: Physical Properties and Stability. Molecular Pharmaceutics 11:7, pages 2381-2389.
Crossref
Erik Sjögren, Bertil Abrahamsson, Patrick Augustijns, Dieter Becker, Michael B. Bolger, Marcus Brewster, Joachim Brouwers, Talia Flanagan, Matthew Harwood, Christian Heinen, René Holm, Hans-Paul Juretschke, Marlies Kubbinga, Anders Lindahl, Viera Lukacova, Uwe Münster, Sibylle Neuhoff, Mai Anh Nguyen, Achiel van Peer, Christos Reppas, Amin Rostami Hodjegan, Christer Tannergren, Werner Weitschies, Clive Wilson, Patricia Zane, Hans Lennernäs & Peter Langguth. (2014) In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects. European Journal of Pharmaceutical Sciences 57, pages 99-151.
Crossref
Christel A.S. Bergström, René Holm, Søren Astrup Jørgensen, Sara B.E. Andersson, Per Artursson, Stefania Beato, Anders Borde, Karl Box, Marcus Brewster, Jennifer Dressman, Kung-I. Feng, Gavin Halbert, Edmund Kostewicz, Mark McAllister, Uwe Muenster, Julian Thinnes, Robert Taylor & Anette Mullertz. (2014) Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs. European Journal of Pharmaceutical Sciences 57, pages 173-199.
Crossref
Riikka Laitinen, Petra A. Priemel, Sachin Surwase, Kirsten Graeser, Clare J. Strachan, Holger Grohganz & Thomas Rades. 2014. Amorphous Solid Dispersions. Amorphous Solid Dispersions 35 90 .
Srinivasa P. S. RaoSuresh B. LakshminarayanaRavinder R. KondreddiMaxime HerveLuis R. CamachoPablo BifaniSarath K. KalapalaJan JiricekNg L. MaBee H. TanSeow H. NgMahesh NanjundappaSindhu RavindranPeck G. SeahPamela ThayalanSiao H. LimBoon H. LeeAnne GohWhitney S. BarnesZhong ChenKerstin GagaringArnab K. ChatterjeeKevin PetheKelli KuhenJohn WalkerGu FengSreehari BabuLijun ZhangFrancesca BlascoDavid BeerMargaret WeaverVeronique DartoisRichard GlynneThomas DickPaul W. SmithThierry T. DiaganaUjjini H. Manjunatha. (2013) Indolcarboxamide Is a Preclinical Candidate for Treating Multidrug-Resistant Tuberculosis. Science Translational Medicine 5:214.
Crossref
Scott L. Childs, Praveen Kandi & Sreenivas Reddy Lingireddy. (2013) Formulation of a Danazol Cocrystal with Controlled Supersaturation Plays an Essential Role in Improving Bioavailability. Molecular Pharmaceutics 10:8, pages 3112-3127.
Crossref
Chris Brough & R.O. WilliamsIIIIII. (2013) Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery. International Journal of Pharmaceutics 453:1, pages 157-166.
Crossref
Riikka Laitinen, Korbinian Löbmann, Clare J. Strachan, Holger Grohganz & Thomas Rades. (2013) Emerging trends in the stabilization of amorphous drugs. International Journal of Pharmaceutics 453:1, pages 65-79.
Crossref
Yiwei Tian, Jonathan Booth, Elizabeth Meehan, David S. Jones, Shu Li & Gavin P. Andrews. (2012) Construction of Drug–Polymer Thermodynamic Phase Diagrams Using Flory–Huggins Interaction Theory: Identifying the Relevance of Temperature and Drug Weight Fraction to Phase Separation within Solid Dispersions. Molecular Pharmaceutics 10:1, pages 236-248.
Crossref
Hywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton & Christopher J. H. Porter. (2013) Strategies to Address Low Drug Solubility in Discovery and Development. Pharmacological Reviews 65:1, pages 315-499.
Crossref
James C. DiNunzio & Dave A. Miller. 2013. Melt Extrusion. Melt Extrusion 161 203 .
Hywel D. Williams, Philip Sassene, Karen Kleberg, Jean-Claude Bakala-N'Goma, Marilyn Calderone, Vincent Jannin, Annabel Igonin, Anette Partheil, Delphine Marchaud, Eduardo Jule, Jan Vertommen, Mario Maio, Ross Blundell, Hassan Benameur, Frédéric Carrière, Anette Müllertz, Christopher J.H. Porter & Colin W. Pouton. (2012) Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 1: Method Parameterization and Comparison of In Vitro Digestion Profiles Across a Range of Representative Formulations. Journal of Pharmaceutical Sciences 101:9, pages 3360-3380.
Crossref
Korbinian Löbmann, Clare Strachan, Holger Grohganz, Thomas Rades, Ossi Korhonen & Riikka Laitinen. (2012) Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions. European Journal of Pharmaceutics and Biopharmaceutics 81:1, pages 159-169.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.